Holdings
Caligan Partners LP
As of Jun 30, 2026, Caligan Partners LP reported 24 positions worth US$2.03B. Largest: Liquidia Corporation, Revolution Medicines, Inc. and Abivax Sa. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Liquidia Corporation | 8.12M | US$647M | no change | Jun 30, 2026 |
| Revolution Medicines, Inc. | 1.96M | US$367M | +309K | Jun 30, 2026 |
| Abivax Sa | 1.56M | US$208M | +96,000 | Jun 30, 2026 |
| Vaxcyte, Inc. | 2.19M | US$127M | +128K | Jun 30, 2026 |
| Exelixis, Inc. | 1.55M | US$84.5M | no change | Jun 30, 2026 |
| Tango Therapeutics, Inc. | 2.5M | US$78.2M | +91,305 | Jun 30, 2026 |
| Avalo Therapeutics, Inc. | 3.16M | US$58.5M | +1.53M | Jun 30, 2026 |
| Xenon Pharmaceuticals Inc. | 890K | US$53.7M | −503K | Jun 30, 2026 |
| Adma Biologics Inc | 5.73M | US$47.9M | +968K | Jun 30, 2026 |
| Lb Pharmaceuticals Inc | 1.44M | US$46.7M | no change | Jun 30, 2026 |